In the preceding three months, 13 analysts have released ratings for ACADIA Pharmaceuticals ACAD, presenting a wide array of ...

Detailed price information for Acadia Pharmaceutica (ACAD-Q) from The Globe and Mail including charting and trades.

Detailed price information for Acadia Pharmaceutica (ACAD-Q) from The Globe and Mail including charting and trades.

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report)’s share price traded down 4.4% during trading on Tuesday following insider selling activity.The stock traded as low as $21.23 and last ...

The ruling marked a significant milestone for ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) to protect its intellectual property rights. Overall, ACAD ranks 1st on our list of Friday’s top performers.

We recently published a list of 10 Surprising Stocks That Skyrocketed Today. In this article, we are going to take a look at where ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) stands against other ...

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) saw unusually large options trading activity on Thursday.Stock traders purchased 2,626 call options on the company. This is an ...

ACADIA PHARMACEUTICALS posted quarterly earnings results on Wednesday, May 7th.The company reported earnings of $0.11 per share, missing estimates of $0.11 by $0.00. The company also reported ...

Acadia Pharmaceuticals CFO sells shares valued at $51,070 ...

Acadia Pharmaceuticals CFO sells shares valued at $51,070. Open in App. Get 45% Off. Sign In; Free Sign Up ...

SAN DIEGO—Mark C. Schneyer, the Executive Vice President and Chief Financial Officer of Acadia Pharmaceuticals Inc. (NASDAQ:ACAD), a $2.47 billion market cap company with strong financial health, ...